MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience.
about
Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing ManagementCurrent approaches and challenges for monitoring treatment response in colon and rectal cancerMagnetic resonance imaging in rectal cancer: a surgeon's perspectiveImaging Advances in Colorectal CancerMRI Local Staging and Restaging in Rectal CancerThe modern anatomical surgical approach to localised rectal cancer.Magnetic resonance imaging for diagnosis and neoadjuvant treatment evaluation in locally advanced rectal cancer: A pictorial review.Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer.MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.Stage and size using magnetic resonance imaging and endosonography in neoadjuvantly-treated rectal cancer.Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging.Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.Systematic review and meta-analysis of the accuracy of MRI and endorectal ultrasound in the restaging and response assessment of rectal cancer following neoadjuvant therapy.Assessing pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review.Clinical value of MRI-detected extramural venous invasion in rectal cancer.Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.Oncological results of extended resection for locally advanced rectal cancer: the value of postirradiation MRI in predicting local recurrence.Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long-term survival in locally advanced rectal cancer treated by chemoradiotherapy.A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protoc17-Week Delay Surgery after Chemoradiation in Rectal Cancer with Complete Pathological Response.Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer.SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.Reply to Akingboye et al.Additional chemotherapy and salvage surgery for poor response to chemoradiotherapy in rectal cancers.[Local imaging of rectal cancer--update 2015: MRI as imaging biomarker].Recognising pitfalls in assessment of tumours by diffusion-weighted MRI: a pictorial essay.Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer.MRI-Based Assessment of Tumor Regression in Rectal Cancer
P2860
Q26743853-E02B4176-7BD6-4A3B-A575-1426B94C3926Q27010257-98BEA085-5E5E-4B26-A814-D15CC7ECD9CBQ27027906-481C165B-1C4D-415A-A699-FA9311CC160BQ28075896-6BDCA1BB-9BC8-45A1-993E-B7D93026D959Q28083539-20FAF169-CDAF-43A1-A097-7AF561E18ED0Q33698397-DAC01EF1-698E-4DD7-9B50-2159A1AAE9BDQ33779869-2A9C4039-711D-4856-A36F-4F59113810A5Q34499632-0687CE40-135F-4FA4-8A51-EAE3BB036DE3Q35885124-C7D57C64-2B7E-4924-B9F9-9417A22BBF74Q36897923-95E9682A-50BA-4A6B-8364-12DE8D1D83EEQ37034524-462B7448-C124-46F5-8BBE-598F5133E2C6Q37322482-44CBA775-5F20-4DDC-B36D-851E912BAA68Q38428481-7C6446B5-6284-4BFE-B3F1-DE7197D70CC2Q38563947-1AAEE3E6-1FE0-43AF-8F10-28ECD3D61F19Q39051367-BFD11CA7-4E33-4643-AF33-5384CA978998Q39277599-212BD24A-68E6-4E16-BA2E-2CEE2CA4DD60Q39399021-A7CEE4B6-37D3-4612-94FA-16B30A3091B2Q40616665-416DA2B9-A1E6-4745-826E-1321FD6379AAQ41556432-2B179C4E-55D8-40B1-B0B6-435533D35A81Q43187814-FE7E56FB-4CD5-482F-90FF-341DC6DC2474Q47554549-DBF60D96-4D38-448A-8D17-E5A7163A9BA1Q47744121-8BE04C26-A05D-4E64-A4B9-A36CB09A96E1Q50062645-652D2438-A7C9-45B8-926E-C45880242175Q50793187-9CB671B6-8DE2-44B1-992B-3E867F5B1C08Q52989202-03950693-BCDD-44E9-BC38-94054CA1F981Q53030301-6BBD3DD5-4278-46D3-9354-489C46BDBEF6Q53081755-79BE52AC-7F1B-436D-B235-021592044905Q55077052-9749CCE5-7B45-4D56-A6DF-923DF1E4A0C5Q57088783-AFF3EBCF-E7A6-47F6-B7F1-FBA3625DF917
P2860
MRI after treatment of locally advanced rectal cancer: how to report tumor response--the MERCURY experience.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MRI after treatment of locally ...... ponse--the MERCURY experience.
@en
type
label
MRI after treatment of locally ...... ponse--the MERCURY experience.
@en
prefLabel
MRI after treatment of locally ...... ponse--the MERCURY experience.
@en
P2093
P356
P1476
MRI after treatment of locally ...... ponse--the MERCURY experience.
@en
P2093
Ashley Guthrie
Christopher George
Fiona Taylor
Lennart K Blomqvist
Nicola Bees
Uday B Patel
P304
P356
10.2214/AJR.11.8210
P407
P50
P577
2012-10-01T00:00:00Z